TABLE 1

Tumor and Normal Tissue Uptake in MDA-MB-361 Tumor-Bearing Mice 72 Hours After Intravenous Injection

Tissue111In-Trastuzumab111In-NLS3-Trastuzumab111In-NLS6-Trastuzumab111In-NLS3-hIgG
Blood2.30 ± 0.372.31 ± 0.482.20 ± 0.123.18 ± 0.51
Bladder2.81 ± 0.532.26 ± 0.372.37 ± 0.223.83 ± 0.66
Large intestine1.59 ± 0.131.20 ± 0.211.26 ± 0.071.36 ± 0.09
Small intestine2.44 ± 0.211.87 ± 0.211.91 ± 0.162.05 ± 0.15
Stomach1.06 ± 0.100.89 ± 0.160.84 ± 0.120.99 ± 0.10
Spleen7.17 ± 0.476.68 ± 0.837.05 ± 1.087.13 ± 0.61
Liver11.46 ± 0.5111.02 ± 0.3712.27 ± 0.4112.60 ± 0.91
Kidney7.95 ± 0.537.70 ± 0.808.01 ± 0.268.23 ± 0.84
Lung3.20 ± 0.212.64 ± 0.332.81 ± 0.053.63 ± 0.33
Heart2.35 ± 0.262.08 ± 0.372.27 ± 0.132.54 ± 0.33
Muscle1.37 ± 0.181.03 ± 0.220.90 ± 0.071.33 ± 0.26
Skin2.11 ± 0.212.10 ± 0.502.05 ± 0.202.90 ± 0.38
Bone marrow2.73 ± 0.712.92 ± 0.122.68 ± 0.283.33 ± 0.54
Tumor13.17 ± 2.22a12.14 ± 1.34b12.62 ± 0.44c4.78 ± 0.76d
  • a-d, b-d, c-dSignificantly different.

  • a-b, a-c, b-cNot significantly different.

  • Statistical comparisons between groups were made by Student t test (P < 0.05). Results are expressed as mean %ID/g ± SEM (n = 6, except bone marrow, where n = 3).